| 2019 | A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy | 이용현 | Article |
| 2026 | Advanced engineering of microbiome-related therapeutics for targeted treatment of inflammatory bowel diseases | 이용현; Xiaoliang Cheng | Review |
| 2019 | Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy | 이용현 | Article |
| 2024 | Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy | 권영주; 이용현; 박서정 | Article |
| 2026 | Applications of Pharmacometrics in Antibody-Drug Conjugate Development | 이용현; Xiaoliang Cheng | Review |
| 2026 | Barrier-reinforcing hyaluronic acid-bilirubin nanodelivery of methylprednisolone for synergistic modulation of the intestinal barrier, immune system, and gut microbiome in colitis | 김성은; 이용현 | Article |
| 2024 | Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy | 김진성; 이용현; 김광명 | Article |
| 2020 | Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets | 이용현 | Article |
| 2020 | Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis | 이용현 | Article |
| 2023 | Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy | 이용현 | Article |
| 2024 | Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy | 이용현 | Article |
| 2023 | Hyaluronic acid-bilirubin Nanoparticles as a Tumor Microenvironment-responsive Nanomedicine for Targeted Cancer Therapy | 이선주 | Master's Thesis |
| 2026 | Inulin-Butyrate Nanogel for Modulation of Gut Microbiome, Intestinal Barrier, and Regulatory T-Cells in Colitis | 이용현 | Article |
| 2025 | Metal-Based Nanomedicines for Inducing Programmed Cell Death to Enhance the Efficacy of Cancer Immunotherapy | 이용현; Xiaoliang Cheng | Review |
| 2021 | Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome | 이용현 | Review |
| 2022 | Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease | 이용현 | Review |
| 2020 | PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood | 이용현 | Article |
| 2026 | Pharmacokinetic/pharmacodynamic modeling of therapeutic antibodies in oncology: current advances and future perspectives | 이용현 | Review |
| 2020 | Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib | 이용현 | Article |
| 2026 | Quantitative systems pharmacology models: unleashing their potential in cancer immunotherapy | 이용현 | Review |
| 2021 | Recent progress in development and applications of second near-infrared (NIR-II) nanoprobes | 이용현 | Review |
| 2023 | ROS-responsive Hyaluronic acid-bilirubin Nanoparticles Encapsulating SN-38 for Targeted Cancer Therapy | 이선아 | Master's Thesis |
| 2022 | Smart pH-responsive nanomedicines for disease therapy | 이용현 | Review |
| 2025 | Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes | 이용현 | Article |
| 2025 | Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance | 윤주영; 이용현; Xiaoliang Cheng | Article |
| 2025 | Topical nanomedicines using lipids, carbohydrates, proteins, and synthetic polymers for enhanced management of skin disorders | 이용현 | Review |
| 2022 | 비정형적 인체 조각을 통한 인간 존재의 모호성 표현 | 이용현 | Master's Thesis |
